InvestorsHub Logo
icon url

Retiredceo

12/02/19 1:47 PM

#231157 RE: biotechtrader2020 #231145

Bio....in your scenario they failed and there are no longer any sales reps....exactly as I said.

Amarin is turning a profit with 400 reps currently. They intend to add 400 more. That will turn a bigger profit as their stable costs were covered with the first 400.

Amarin is expanding an already successful business model. If all they did was add 400 more reps it would probably be successful. However the fda is going to help them out. Canada is too. When that happens there will be an increased demand with or without sales reps.

Any talk of Amarin losing money in the future is foolish. It’s a matter of how much will they make.